Display Settings:

Format

Send to:

Choose Destination
    AAPS J. 2005 Nov 17;7(4):E786-812.

    Equivalence studies for complex active ingredients and dosage forms.

    Source

    United States Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, USA.

    Abstract

    This article examines the United States Pharmacopeia (USP) and its role in assessing the equivalence and inequivalence of biological and biotechnological drug substances and products-a role USP has played since its founding in 1820. A public monograph in the United States Pharmacopeia-National Formulary helps practitioners and other interested parties understand how an article's strength, quality, and purity should be controlled. Such a monograph is a standard to which all manufactured ingredients and products should conform, and it is a starting point for subsequent-entry manufacturers, recognizing that substantial additional one-time characterization studies may be needed to document equivalence. Review of these studies is the province of the regulatory agency, but compendial tests can provide clarity and guidance in the process.

    PMID:
    16594632
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2750949
    Free PMC Article

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk